HIGH RISK CLL

Clinical trials for HIGH RISK CLL explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK CLL trials appear

Sign up with your email to follow new studies for HIGH RISK CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tailored cocktail aims to wipe out CLL in young High-Risk patients

Disease control Ongoing

This phase 2 trial tests a personalized approach for young adults (18-65) with high-risk chronic lymphocytic leukemia (CLL) who haven't been treated before. Patients first get a combination of venetoclax and obinutuzumab, then their treatment is adjusted based on whether cancer c…

Matched conditions: HIGH RISK CLL

Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

HIGH RISK CLL

Get alerted when new HIGH RISK CLL trials appear

Tailored cocktail aims to wipe out CLL in young High-Risk patients